The rollout of paediatric dolutegravir and virological outcomes among children living with HIV in Mozambique

• Váldodahkkit: Ivete Meque (Dahkki), Nicole Herrera (Dahkki), Amâncio Nhangave (Dahkki), Dórcia Mandlate (Dahkki), Rui Guilaze (Dahkki), Ana Tambo (Dahkki), Abdul Mussa (Dahkki), Nilesh Bhatt (Dahkki), Michelle M. Gill (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: AOSIS, 2024-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: In 2022, Mozambique introduced Dolutegravir 10mg (pDTG), as part of paediatric antiretroviral therapy for children weighing 20 kg. Understanding real-world challenges during national rollout can strengthen health systems in resource-limited settings. Objectives: We described the transiti...